Страница 6 из 6 J Am Soc Nephrol 2001;12:602-5. Fauvel JP, Najem R, Ryon B, et al. Effects of rilmenidine on stress-induced peak blood pressure and renal function. J Cardiovasc Pharmacol 1999;34:41-5. Bauduceau B, Mayaudon H, Dupuy O. Rilmenidine in hypertensive type 2 diabetic: a controlled pilot study versus captopril. J Cardivasc Risk 2000;7:57-61. Krespi PG, Makris TK, Hatzizacharias AN, et al. Moxonidine effect on microalbuminuria, thrombomodulin, and plasminogen activator inhibitor-1 level in patient with essential hypertension. Cardivasc Drags Ther 1998; 12:463-7. Haenni A, Lithell H. Moxonidine improves insulin sensitivity in insulin-resistant hypertensives. J Hypertens 1999;17(S3):29-35. De Luca N, Izzo R, Fontana D, et al. Haemodynamic and metabolic effects of rilmenidine in hypertensive patients with metabolic syndrome X. A double-blind parallel study versus amlodipine. J Hypertens 2000; 18:1515-22. Lambert AE, Mpoy M, Vandeleene B, et al. Treatment of hypertension in diabetic patients. Am J Med 1989;87:30-5. Elisaf MS, Petris C, Bairaktari E, et al. The effect of moxonidine on plasma Источник: rusmg
|